Bustos-Valenzuela Juan C, Fujita Andre, Halcsik Erik, Granjeiro Jose M, Sogayar Mari C
Chemistry Institute, Department of Biochemistry, Cell and Molecular Therapy Centre (NUCEL), University of São Paulo, Avenida Prof, Lineu Prestes, 748 Bloco 9S, São Paulo, SP 05508-000, Brazil.
BMC Res Notes. 2011 Sep 26;4:370. doi: 10.1186/1756-0500-4-370.
We set out to analyse the gene expression profile of pre-osteoblastic C2C12 cells during osteodifferentiation induced by both rhBMP2 and rhBMP7 using DNA microarrays. Induced and repressed genes were intercepted, resulting in 1,318 induced genes and 704 repressed genes by both rhBMP2 and rhBMP7. We selected and validated, by RT-qPCR, 24 genes which were upregulated by rhBMP2 and rhBMP7; of these, 13 are related to transcription (Runx2, Dlx1, Dlx2, Dlx5, Id1, Id2, Id3, Fkhr1, Osx, Hoxc8, Glis1, Glis3 and Cfdp1), four are associated with cell signalling pathways (Lrp6, Dvl1, Ecsit and PKCδ) and seven are associated with the extracellular matrix (Ltbp2, Grn, Postn, Plod1, BMP1, Htra1 and IGFBP-rP10). The novel identified genes include: Hoxc8, Glis1, Glis3, Ecsit, PKCδ, LrP6, Dvl1, Grn, BMP1, Ltbp2, Plod1, Htra1 and IGFBP-rP10.
BMPs (bone morphogenetic proteins) are members of the TGFβ (transforming growth factor-β) super-family of proteins, which regulate growth and differentiation of different cell types in various tissues, and play a critical role in the differentiation of mesenchymal cells into osteoblasts. In particular, rhBMP2 and rhBMP7 promote osteoinduction in vitro and in vivo, and both proteins are therapeutically applied in orthopaedics and dentistry.
Using DNA microarrays and RT-qPCR, we identified both previously known and novel genes which are upregulated by rhBMP2 and rhBMP7 during the onset of osteoblastic transdifferentiation of pre-myoblastic C2C12 cells. Subsequent studies of these genes in C2C12 and mesenchymal or pre-osteoblastic cells should reveal more details about their role during this type of cellular differentiation induced by BMP2 or BMP7. These studies are relevant to better understanding the molecular mechanisms underlying osteoblastic differentiation and bone repair.
我们着手使用DNA微阵列分析前成骨细胞C2C12细胞在rhBMP2和rhBMP7诱导的骨分化过程中的基因表达谱。截获了诱导基因和抑制基因,结果显示rhBMP2和rhBMP7均诱导了1318个基因并抑制了704个基因。我们通过RT-qPCR筛选并验证了24个被rhBMP2和rhBMP7上调的基因;其中,13个与转录相关(Runx2、Dlx1、Dlx2、Dlx5、Id1、Id2、Id3、Fkhr1、Osx、Hoxc8、Glis1、Glis3和Cfdp1),4个与细胞信号通路相关(Lrp6、Dvl1、Ecsit和PKCδ),7个与细胞外基质相关(Ltbp2、Grn、Postn、Plod1、BMP1、Htra1和IGFBP-rP10)。新鉴定出的基因包括:Hoxc8、Glis1、Glis3、Ecsit、PKCδ、LrP6、Dvl1、Grn、BMP1、Ltbp2、Plod1、Htra1和IGFBP-rP10。
骨形态发生蛋白(BMPs)是转化生长因子-β(TGFβ)超家族蛋白的成员,可调节各种组织中不同细胞类型的生长和分化,在间充质细胞向成骨细胞的分化中起关键作用。特别是,rhBMP2和rhBMP7在体外和体内均能促进骨诱导,这两种蛋白均已在骨科和牙科治疗中应用。
通过DNA微阵列和RT-qPCR,我们鉴定出了在成肌前体细胞C2C12向成骨细胞转分化起始过程中被rhBMP2和rhBMP7上调的已知基因和新基因。随后在C2C12以及间充质或前成骨细胞中对这些基因的研究应能揭示它们在由BMP2或BMP7诱导的此类细胞分化过程中作用的更多细节。这些研究对于更好地理解成骨细胞分化和骨修复的分子机制具有重要意义。